Aclarion Inc reports a Return on Equity (ROE) of -40.96%.

What is ACON's dividend yield?

Aclarion Inc offers a dividend yield of 0.00%.

What is ACON's Quality Score?

Our AI rates ACON's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ACON?

Our AI Timing Score for ACON is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ACON belong to?

Aclarion Inc is classified under the Healthcare >> Health Information Services sector on the NASDAQ exchange

Aclarion Inc (ACON) Stock Price, Quality Score & AI Analysis

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ACON AI Analysis Summary

Our AI summary for ACON: Aclarion Inc (NASDAQ), Healthcare >> Health Information Services sector. The stock currently trades at a P/E of 0.00, ROE of -40.96%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ACON

Aclarion Inc

USD 2.25

0.23 (11.39%) Day Change

Watchlist Portfolio Compare Chart

0.05

D/E

-41.0%

ROE

-39.0%

ROA

0.00%

Div Yield

ACLARION INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.25 Price 0.23 (11.39%) Day Change	NEWS SCORE: 98

ACON, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	98
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.25
PBV / Sector	0.25 / 6.33 GREAT
Earning Per Share	-3.64

PE / Sector	N/A / 46.50
PEG or PE/Growth / Sector	N/A / -0.41
Average 1M Daily Value	0.11 M GREAT
Average 1W Daily Value	0.14 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-10,336.12 / 24.51
NPM Average (%) / Sector	-10,677.92 / -3.79
NPM Change Average (%) / Sector	15.29 / -69.35 GOOD
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-39.00 / 8.16
ROA Average (%) / Sector	-172.68 / -0.84
ROA Change Average (%) / Sector	-15.74 / -77.75
ROE (%) / Sector	-40.96 / 17.39
ROE Average (%) / Sector	-92.22 / 0.83
ROE Change Average (%) / Sector	-159.70 / -80.78
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.21
Dividend Average (%) / Sector	N/A / 4.02
Dividend Change Average (%) / Sector	N/A / 2.86

Registration Details

Analyze Date	2026-08-01 07:59:25
Symbol	ACON
Name	ACLARION INC
Sector	Healthcare >> Health Information Services
Market	NASDAQ
Listed Shares	2.46 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	4.97 / 4,079.00

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 8181 Arista Place, Broomfield, CO, United States, 80021

Phone: 833 275 2266

Website: https://www.aclarion.com

Sector: Healthcare >> Health Information Services

Description: Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.